Mathematical modeling suggests that entry-inhibitor bulevirtide may interfere with hepatitis D virus clearance from circulation

J Hepatol. 2022 May;76(5):1229-1231. doi: 10.1016/j.jhep.2021.12.030. Epub 2022 Jan 5.

¹ The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA; Network Science Institute, Northeastern University, Boston, MA, USA.
² The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
³ Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
⁴ The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. Electronic address: hdahari@luc.edu.

No abstract available

Keywords: HDV kinetics; bulevirtide; mathematical modeling.

Publication types